IOVANCE BIOTHERAPEUTICS, INC. Lease Agreements
11 Contracts & Agreements
- Third Amendment to the Lease Agreement, effective as of November 1, 2021, between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC (Filed With SEC on February 24, 2022)
- Lease Agreement dated as of February 8, 2021, by and between Iovance Biotherapeutics, Inc. and ARE-San Francisco No. 63, LLC (Filed With SEC on February 9, 2021)
- Second Amendment to the Lease Agreement, effective as of June 30, 2020, between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC (Filed With SEC on August 6, 2020)
- First Amendment to the Lease Agreement, effective as of August 20, 2019, between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC (Filed With SEC on November 4, 2019)
- First Amendment to the Office Lease, effective as of June 19, 2019, between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC (Filed With SEC on November 4, 2019)
- First Amendment to the Lease Agreement dated as of June 19, 2019, by and between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC (Filed With SEC on June 21, 2019)
- Lease Agreement dated as of May 28, 2019, by and between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC (Filed With SEC on June 3, 2019)
- Office Lease, effective as of October 19, 2018, between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC (Filed With SEC on October 25, 2018)
- SUBLEASE AGREEMENT (Filed With SEC on May 1, 2017)
- OFFICE LEASE (Filed With SEC on August 8, 2016)
- LEASE (Filed With SEC on August 8, 2014)
